0.045
price down icon8.20%   -0.005
 
loading
Precedente Chiudi:
$0.05
Aprire:
$0.05
Volume 24 ore:
6.03M
Relative Volume:
0.90
Capitalizzazione di mercato:
$2.94M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-15.00%
1M Prestazione:
-60.29%
6M Prestazione:
-94.59%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$0.044
$0.05
Intervallo di 1 settimana:
Value
$0.044
$0.058
Portata 52W:
Value
$0.044
$4.31

Psyence Biomedical Ltd Stock (PBM) Company Profile

Name
Nome
Psyence Biomedical Ltd
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
10
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
PBM's Discussions on Twitter

Confronta PBM con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
PBM 0.045 2.94M 0 0 0 0.00
VRTX 449.80 115.43B 10.63B -479.80M -1.35B 13.33
REGN 747.38 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 591.88 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 246.15 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.49 24.89B 3.30B -501.07M 1.03B 11.54

Psyence Biomedical Ltd Borsa (PBM) Ultime notizie

pulisher
Nov 20, 2024

Psyence Biomedical Secures Extension To Meet Nasdaq Compliance Standards - Benzinga

Nov 20, 2024
pulisher
Nov 20, 2024

Psyence Biomedical to consolidate shares in bid to keep Nasdaq listing - Green Market Report

Nov 20, 2024
pulisher
Nov 20, 2024

Psyence Biomedical gets extension to show compliance with Nasdaq’s listing rules - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing - The Manila Times

Nov 20, 2024
pulisher
Nov 20, 2024

Psyence Biomed granted Nasdaq listing extension - Investing.com

Nov 20, 2024
pulisher
Nov 20, 2024

Psyence Biomedical Announces Favorable Result Of Nasdaq Listing Qualifications Hearing - XM

Nov 20, 2024
pulisher
Nov 20, 2024

Psyence Biomedical Secures Nasdaq Extension, Plans 1-for-75 Share Consolidation | PBM Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 20, 2024

Psyence Biomedical fell on 75-to-1 share consolidation and Nasdaq delisting notice - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Psyence Biomed announces share consolidation date - Investing.com India

Nov 19, 2024
pulisher
Nov 19, 2024

Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation - The Manila Times

Nov 19, 2024
pulisher
Nov 19, 2024

Psyence Biomedical Implements 1-for-75 Share Consolidation to Meet Nasdaq Requirements | PBM Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 19, 2024

Psyence Biomed announces share consolidation date By Investing.com - Investing.com Canada

Nov 19, 2024
pulisher
Nov 12, 2024

Psyence Biomedical Announces Results from Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination from Nasdaq - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Psyence Biomedical Shareholders Approve 75:1 Stock Split Amid Nasdaq Compliance Challenge | PBM Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

Psyence Biomedical Announces Results from Annual and - GlobeNewswire

Nov 12, 2024
pulisher
Oct 31, 2024

Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group’s Stake in PsyLabs - GlobeNewswire

Oct 31, 2024
pulisher
Oct 31, 2024

Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabs - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group's Stake in PsyLabs - The Manila Times

Oct 31, 2024
pulisher
Oct 30, 2024

Where Do Analysts See Psyence Biomedical Ltd. (NASDAQ: PBM) Heading? - Stocks Register

Oct 30, 2024
pulisher
Oct 26, 2024

Bullish Prospects For Psyence Biomedical Ltd. (NASDAQ: PBM) Shares In 2024 - Stocks Register

Oct 26, 2024
pulisher
Oct 25, 2024

Natural Gas LDay (F) (HHM19) Quote - The Globe and Mail

Oct 25, 2024
pulisher
Oct 25, 2024

Psyence Biomed adds Australian site for psilocybin trial - Investing.com

Oct 25, 2024
pulisher
Oct 24, 2024

Psyence Biomed adds Australian site for psilocybin trial By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 24, 2024

Psyence Biomed Announces Recruitment of Second Clinical - GlobeNewswire

Oct 24, 2024
pulisher
Oct 24, 2024

Psyence Biomed Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care - StockTitan

Oct 24, 2024
pulisher
Oct 23, 2024

Psyence Biomedical Sets Annual General Meeting for November 12 - Investing.com

Oct 23, 2024
pulisher
Oct 23, 2024

Psyence Biomedical Plans Key Shareholder Meeting - TipRanks

Oct 23, 2024
pulisher
Oct 23, 2024

Psyence Biomedical Sets Annual General Meeting for November 12 By Investing.com - Investing.com UK

Oct 23, 2024
pulisher
Oct 17, 2024

Psyence Biomed Provides Progress Update on PsyLabs E.U. Good Manufacturing Practices (GMP) Certified Active Pharmaceutical Ingredient (API) Development - The Manila Times

Oct 17, 2024
pulisher
Oct 14, 2024

Psyence Biomedical Ltd. (PBM) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle

Oct 14, 2024
pulisher
Oct 14, 2024

How analysts predict Psyence Biomedical Ltd. (PBM) will perform this quarter? - US Post News

Oct 14, 2024
pulisher
Oct 14, 2024

Psyence Group Enters into Debt-for-Equity Swap Agreement with its NASDAQ-Listed Associate, Psyence Biomedical - The Manila Times

Oct 14, 2024
pulisher
Oct 14, 2024

Gaining Ground: Psyence Biomedical Ltd. (PBM) Closes Higher at 0.10, Up 5.70 - The Dwinnex

Oct 14, 2024
pulisher
Oct 14, 2024

What is Psyence Biomedical Ltd. (PBM) Stock Return on Shareholders’ Capital? - SETE News

Oct 14, 2024
pulisher
Oct 09, 2024

Psyence Biomedical Ltd. [PBM] is -98.82% lower this YTD. Is it still time to buy? - The DBT News

Oct 09, 2024
pulisher
Oct 09, 2024

Investor Alert: What’s Really Going On At Psyence Biomedical Ltd. (NASDAQ: PBM) - Stocks Register

Oct 09, 2024
pulisher
Oct 09, 2024

There is no way Psyence Biomedical Ltd. (PBM) can keep these numbers up - SETE News

Oct 09, 2024
pulisher
Oct 08, 2024

Psyence Biomedical Converts Debt to Equity - TipRanks

Oct 08, 2024
pulisher
Oct 08, 2024

PBM’s Stock Journey: What Investors Need to Know About Psyence Biomedical Ltd.’s Performance - The InvestChronicle

Oct 08, 2024
pulisher
Oct 07, 2024

Is it possible to buy Psyence Biomedical Ltd.(PBM) shares at a good price now? - US Post News

Oct 07, 2024
pulisher
Oct 07, 2024

Financial Analysis: Psyence Biomedical Ltd. (PBM)’s Ratios Unveil Key Insights - The Dwinnex

Oct 07, 2024
pulisher
Oct 05, 2024

PBMPsyence Biomedical Ltd. Common Shares Latest Stock News & Market Updates - StockTitan

Oct 05, 2024
pulisher
Oct 05, 2024

Psyence Biomed halts Clairvoyant Therapeutics acquisition - Investing.com

Oct 05, 2024
pulisher
Oct 04, 2024

Psyence Biomed halts Clairvoyant Therapeutics acquisition By Investing.com - Investing.com UK

Oct 04, 2024
pulisher
Oct 04, 2024

Psyence Biomed Provides Update on Previously Announced Acquisition of Clairvoyant - The Manila Times

Oct 04, 2024
pulisher
Oct 02, 2024

Views of Wall Street’s Leading Experts on Psyence Biomedical Ltd. - SETE News

Oct 02, 2024
pulisher
Sep 30, 2024

Psyence Biomedical Ltd. (PBM) Stock: Uncovering 52-Week Market Trends - The InvestChronicle

Sep 30, 2024
pulisher
Sep 30, 2024

Market Momentum: Psyence Biomedical Ltd. (PBM) Registers a -1.10 Decrease, Closing at 0.11 - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

Psyence Biomedical Ltd. (PBM) stock analysis: A comprehensive overview - US Post News

Sep 30, 2024
pulisher
Sep 27, 2024

Psyence Biomedical Ltd. (PBM): Be Patient, You Will Learn - Stocks Register

Sep 27, 2024
pulisher
Sep 25, 2024

An analyst sees good growth prospects for Psyence Biomedical Ltd. (PBM) - SETE News

Sep 25, 2024

Psyence Biomedical Ltd Azioni (PBM) Dati Finanziari

Non sono disponibili dati finanziari per Psyence Biomedical Ltd (PBM). Controlla altri titoli per ulteriori informazioni.

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):